UBS AM

UBS AM’s CytomX Therapeutics CTMX Stock Holding History

UBS AM’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$890K	Buy	+189,400	New	+$961K	﹤0.01%	2380
2021 Q4	–	Sell	-64,369	Closed	-$328K	–	2862
2021 Q3	$328K	Sell	64,369 -480	-0.7%	-$2.57K	﹤0.01%	2604
2021 Q2	$410K	Buy	64,849 +35,254	+119%	+$275K	﹤0.01%	2591
2021 Q1	$229K	Sell	29,595 -19,776	-40%	-$157K	﹤0.01%	2541
2020 Q4	$323K	Hold	49,371	–	–	﹤0.01%	2399
2020 Q3	$328K	Buy	49,371 +18,440	+60%	+$137K	﹤0.01%	2285
2020 Q2	$258K	Buy	30,931 +3,513	+13%	+$32.6K	﹤0.01%	2330
2020 Q1	$210K	Sell	27,418 -7,165	-21%	-$50K	﹤0.01%	2260
2019 Q4	$287K	Sell	34,583 -2,471	-7%	-$16.7K	﹤0.01%	2381
2019 Q3	$273K	Buy	37,054 +8,490	+30%	+$83.8K	﹤0.01%	2485
2019 Q2	$320K	Buy	28,564 +3,974	+16%	+$41.7K	﹤0.01%	2391
2019 Q1	$264K	Buy	24,590 +11,590	+89%	+$171K	﹤0.01%	2363
2018 Q4	$196K	Hold	13,000	–	–	﹤0.01%	2398
2018 Q3	$241K	Buy	13,000 +900	+7%	+$20.5K	﹤0.01%	2360
2018 Q2	$277K	Buy	+12,100	New	+$309K	﹤0.01%	2340

Other funds holding CTMX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return